thiazoles has been researched along with Bone Marrow Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carter, YM; Chen, H; Gamblin, TC; Kunnimalaiyaan, M; Kunnimalaiyaan, S | 1 |
| Dent, P | 1 |
2 other study(ies) available for thiazoles and Bone Marrow Neoplasms
| Article | Year |
|---|---|
Specific glycogen synthase kinase-3 inhibition reduces neuroendocrine markers and suppresses neuroblastoma cell growth.
Topics: Antineoplastic Agents; Apoptosis; Basic Helix-Loop-Helix Transcription Factors; Biomarkers, Tumor; Bone Marrow Neoplasms; Cell Line, Tumor; Cell Proliferation; Chromogranin A; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Neuroblastoma; Phosphorylation; Thiazoles; Tyrosine; Urea | 2014 |
New methods to control neuroblastoma growth.
Topics: Antineoplastic Agents; Biomarkers, Tumor; Bone Marrow Neoplasms; Cell Proliferation; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Neuroblastoma; Thiazoles; Urea | 2014 |